SDGR: Schrödinger, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 1,528.67
Enterprise Value ($M) 1,368.25
Book Value ($M) 449.43
Book Value / Share 7.06
Price / Book 3.40
NCAV ($M) 236.53
NCAV / Share 3.71
Price / NCAV 6.46

Profitability (mra)
Return on Invested Capital (ROIC) -0.31
Return on Assets (ROA) -0.22
Return on Equity (ROE) -0.32

Liquidity (mrq)
Quick Ratio 4.11
Current Ratio 4.11

Balance Sheet (mrq) ($M)
Current Assets 456.40
Assets 669.30
Liabilities 219.87
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-13 13G/A Rubric Capital Management LP
02-04 13G Sumitomo Mitsui Trust Holdings, Inc.
2024-02-13 13G/A Vanguard Group Inc 10.78 1.60
2024-01-23 13G/A BlackRock, Inc. 13.90 3.85

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-07-31 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-01 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-02-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-21 146,098 1,004,823 14.54
2025-02-20 320,768 1,358,987 23.60
2025-02-19 165,788 721,638 22.97
2025-02-18 300,463 1,876,718 16.01

(click for more detail)

Similar Companies
RXRX – Recursion Pharmaceuticals, Inc. SANA – Sana Biotechnology, Inc.
SCPH – scPharmaceuticals Inc. SLDB – Solid Biosciences Inc.
SLRN – Acelyrin, Inc.


Financial data and stock pages provided by
Fintel.io